1. Home
  2. MRT vs SGMT Comparison

MRT vs SGMT Comparison

Compare MRT & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marti Technologies Inc.

MRT

Marti Technologies Inc.

HOLD

Current Price

$1.43

Market Cap

159.0M

ML Signal

HOLD

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$7.46

Market Cap

169.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRT
SGMT
Founded
2018
2006
Country
Turkey
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
159.0M
169.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
MRT
SGMT
Price
$1.43
$7.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$3.58
$26.13
AVG Volume (30 Days)
55.6K
1.2M
Earning Date
08-08-2018
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,000,000.00
Revenue This Year
$72.36
N/A
Revenue Next Year
$95.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.12
$4.50
52 Week High
$3.11
$11.41

Technical Indicators

Market Signals
Indicator
MRT
SGMT
Relative Strength Index (RSI) 33.34 58.68
Support Level N/A $7.09
Resistance Level $2.26 $8.80
Average True Range (ATR) 0.13 0.39
MACD -0.03 0.10
Stochastic Oscillator 41.16 71.05

Price Performance

Historical Comparison
MRT
SGMT

About MRT Marti Technologies Inc.

Marti Technologies Inc is Turkiye's urban mobility platform, helping to solve the country's transportation needs through tech-enabled services powered by a single mobility super app. The Group aims to offer tech-enabled urban transportation services to consumers across Turkiye through three service offerings: ride-hailing, delivery, and two-wheeled electric vehicle services. The Group's ride-hailing service matches consumers with car, motorcycle, and taxi drivers. The Group's delivery service provides same-hour package delivery by leveraging the Group's existing network of car and motorcycle drivers and consumer base.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: